在美的控股之前，万东医疗控制权曾几经更迭。 上任8个月后，万东医疗董事长辞职。 1月26日，万东医疗（600055.SH）发布公告称，公司董事长马赤兵因个人原因辞去公司一切职务，离 任后，马赤兵将不在公司及控股子公司任职。董事会对其在任期间的履职表示感谢。 与此同时，美的集团（000333.SZ、0300.HK）核心高管王建国被选举为新任董事长，任期自公司第十 届董事会第十三次会议审议通过之日起至公司第十届董事会任期届满之日止。资料显示，王建国现任美 的集团执行董事、执行总裁，并同时兼任集团新能源事业部总裁、美的医疗总裁等要职。 炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 来源 | 野马财经 作者丨孙梦圆 截至1月28日，万东医疗报收16.16元/股，总市值113.6亿元。 图源：罐头图库 五年换三帅 自2021年美的集团成为万东医疗控股股东以来，公司董事长已三度更迭。 首任"美的系"掌门人胡自强，职业生涯涵盖GE、三星等跨国公司，曾任无锡小天鹅副总经理，后在美 的集团历任中央研究院院长、副总裁兼首席技术官（CTO）。2021年中，本已准备退休的胡自强，应集 团战略需要转而出任万 ...

Core Viewpoint - WanDong Medical has undergone a leadership change with the resignation of Chairman Hu Ziqiang and the election of Ma Chibing as the new chairman, which has led to a slight increase in stock price, indicating market confidence in the new leadership [1][3]. Company Overview - WanDong Medical, established in 1997 and listed on the Shanghai Stock Exchange, specializes in the research, production, sales, and after-sales service of large medical imaging equipment, particularly digital X-ray systems [1]. - The company holds a leading position in the domestic market for digital X-ray photography systems (DR) and is in the first tier for mobile digital X-ray systems [1]. Financial Performance - In 2024, WanDong Medical's medical device business reported a revenue increase of 23.01%, but the cost of sales rose by 33.21%, resulting in a decrease in gross margin by 4.92 percentage points [2]. - The company's revenue from 2021 to 2024 showed fluctuations, with revenues of 11.56 billion, 11.21 billion, 12.37 billion, and 15.24 billion respectively, reflecting a growth rate of 2.14%, -3.02%, 10.3%, and 23.26% [4]. - The net profit for the same period was 1.83 billion, 1.75 billion, 1.89 billion, and 1.57 billion, with growth rates of -16.98%, -4.27%, 7.51%, and -16.54% [4]. Market Strategy - In response to market demands, WanDong Medical is upgrading its products to high-end full-field digital X-ray systems and plans to emphasize the creation of a smart medical ecosystem [2]. - The company is also facing challenges with product delays due to increased customer expectations and competition from new products in the market [3]. Shareholder Structure - Midea Group is the controlling shareholder of WanDong Medical, holding 45.46% of the shares, and has been involved in the company's management since 2021 [4].